Chen-Chen Lee Selected Research

Chen-Chen Lee Research Topics

Disease

26	Inflammation (Inflammations) 01/2023 - 06/2004
18	Asthma (Bronchial Asthma) 11/2020 - 02/2009
16	Respiratory Hypersensitivity 01/2019 - 06/2004
7	Eosinophilia 10/2013 - 01/2008
5	Neoplasms (Cancer) 08/2022 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
3	Airway Remodeling 11/2020 - 09/2012
3	Infections 07/2014 - 01/2008
3	Hypersensitivity (Allergy) 01/2008 - 12/2002
2	Carcinogenesis 01/2021 - 05/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2018 - 05/2013
2	Lung Neoplasms (Lung Cancer) 05/2017 - 01/2016
2	Stroke (Strokes) 09/2005 - 06/2004
1	Pneumonia (Pneumonitis) 02/2023
1	Fibrosis (Cirrhosis) 02/2023
1	Lung Diseases (Lung Disease) 02/2023
1	Systemic Scleroderma (Systemic Sclerosis) 02/2023
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Adenoviridae Infections (Adenovirus Infections) 01/2019
1	Erythema 10/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2017
1	Periodontitis 01/2016
1	Neuroinflammatory Diseases 01/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Hyperplasia 01/2014

Drug/Important Bio-Agent (IBA)

15	OvalbuminIBA 11/2020 - 01/2008
11	CytokinesIBA 11/2020 - 01/2008
7	Immunoglobulin E (IgE)IBA 01/2018 - 06/2004
7	Interleukin-5 (Interleukin 5)IBA 10/2017 - 01/2008
6	InterleukinsIBA 10/2017 - 02/2009
6	AntigensIBA 02/2015 - 01/2008
6	Interleukin-4 (Interleukin 4)IBA 09/2012 - 06/2004
5	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2011
5	Interleukin-13IBA 10/2017 - 12/2010
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 10/2018
4	LigandsIBA 01/2019 - 01/2016
3	SteroidsIBA 01/2019 - 05/2013
3	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2018 - 09/2012
3	Small Interfering RNA (siRNA)IBA 04/2014 - 02/2009
3	Environmental Pollutants (Pollutants, Environmental)IBA 01/2008 - 12/2002
3	Fossil Fuels (Fossil Fuel)IBA 01/2008 - 12/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 11/2020
2	Peptides (Polypeptides)IBA 01/2021 - 01/2019
2	CollagenIBA 01/2019 - 10/2013
2	ferulic acid (sodium ferulate)IBA 01/2017 - 01/2015
2	zerumboneIBA 01/2017 - 02/2015
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016 - 05/2013
2	Methacholine Chloride (Methacholine)FDA Link 02/2015 - 06/2004
2	HMGB1 Protein (HMG1)IBA 01/2015 - 10/2013
2	AllergensIBA 01/2014 - 06/2004
2	shikoninIBA 09/2011 - 12/2010
2	Gasoline (Diesel Fuel)IBA 09/2005 - 06/2004
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2023
1	beta-(5-hydroxy-2-pyridyl)alanineIBA 01/2023
1	LipofuscinIBA 01/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	VaccinesIBA 08/2022
1	Amino Acids FDA Link 01/2021
1	Interleukin-17 ReceptorsIBA 01/2021
1	Particulate MatterIBA 09/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Myristoylated Alanine-Rich C Kinase SubstrateIBA 01/2019
1	Imiquimod (Aldara)FDA LinkGeneric 10/2018
1	baicalinIBA 10/2018
1	Interleukin-23 (Interleukin 23)IBA 10/2018
1	ovatodiolideIBA 10/2017
1	Interleukin-33IBA 10/2017
1	DiterpenesIBA 10/2017
1	osthol (osthole)IBA 08/2017
1	Glycogen Synthase Kinase 3 betaIBA 05/2017
1	Transcription Factors (Transcription Factor)IBA 05/2017
1	VimentinIBA 05/2017
1	XenobioticsIBA 01/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016
1	Complex MixturesIBA 01/2016
1	Immunoglobulin G (IgG)IBA 02/2015
1	Therapeutic UsesIBA 02/2015
1	AntibodiesIBA 02/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2014
1	Zinc Oxide FDA Link 07/2014
1	TropomyosinIBA 04/2014
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 04/2014
1	Phosphotransferases (Kinase)IBA 04/2014
1	Nerve Growth Factor (NGF)IBA 04/2014
1	sesaminIBA 01/2014
1	PolyphenolsIBA 01/2014
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014
1	Whey ProteinsIBA 05/2013
1	Chemokine CCL11IBA 09/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2012
1	brazilinIBA 09/2012

Therapy/Procedure

5	Therapeutics 01/2021 - 02/2009
2	Oral Administration 08/2017 - 02/2015
1	Immunotherapy 01/2019
1	Ligation 01/2016